DB
Danielle Brill Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
32
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
92.3%
Neutral
7.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Credit Services
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $83 |
36%
upside
| 1 | +5.4% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Buy
Maintained
| $95 |
43%
upside
| 2 | +11% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Buy
Maintained
| $140 |
5%
upside
| 2 | +0.55% |
0
%
| 17 Feb ‘26 15 days ago |
|
|
|
Buy
Maintained
| $38 |
42%
upside
| 2 | +21% |
0
%
| 29 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $60 |
119%
upside
| 1 | +13% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Hold
Maintained
| $22 |
19%
downside
| 1 | -42% |
–
| 8 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $45 |
58%
upside
| 1 | -8.7% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $63 |
2%
upside
| 1 | +37% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $530 |
62%
upside
| 1 | +5.1% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $190 |
40%
upside
| 1 | +51% |
0
%
| 16 Dec ‘25 2 months ago |
|